NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Nixxy, Inc. (NASDAQ:NIXX), or Nixxy, or the Company, today announced preliminary operational metrics for its Auralink AI subsidiary, highlighting ...
Assembly Biosciences, Inc. reported progress in its clinical development of antiviral candidates, with data from multiple programs expected in 2025. Specifically, interim Phase 1b data for long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback